Daily Stock List
Medisafe 1 Technologies Corp. (MFTH)
Penny Stock Rumble reported today on Medisafe 1 Technologies Corp. (MFTH), PennyTrader Publisher, OTCPicks, OTC Advisors, Penny Stock Beats, Momentum Beats did earlier, and we highlight the Company, here at the QualityStocks Daily Newsletter.
Headquartered in Jerusalem, Israel, Medisafe 1 Technologies Corp. is a developer of patented technologies that physically prevent unauthorized administration of prescription medications. The Company looks to prevent, effectively, unauthorized administration of a drug or medicinal substance by hypodermic needle. Their patented technology is a medical assembly with a locking mechanism intended to ensure the substance cannot undergo release from the hypodermic needle without positive pre-matching between the substance and its intended patient.
The Company’s vision is the administering of the right drug with the right dose to the right patient at the right time. Their technology is the world's first U.S. patented (Patent No. 7,347,841 B2 granted on March 25, 2008) technology to eliminate administration of incorrect medicinal substances by hypodermic needle. Medisafe 1 has developed a fully operational prototype with PIA Electronics Ltd. The Company has agreed to pay PIA Electronics a commission based upon sales revenue in the amount of ten percent of all future royalties from the sale and/or licensing of a product that is based on the working prototype manufactured by PIA Electronics.
The principle features of the prototype design includes a protector which fits over a proportion of the medicine assembly, a bar code and locking element, an electrically operated device to control the locking element, and a connection to a bar code reader. The protector includes an enclosure that surrounds a container of medicine, whether it is intended for oral intake, transdermal delivery, or any other kind of medicinal administration.
Yesterday, Medisafe 1 Technologies announced that they intend to issue a one-time special dividend to all existing shareholders pending the perpetual license sale of technology rights to a third party. As the Company has reported recently, they have advanced negotiations to enter into a non-exclusive perpetual license agreement that would transfer rights for the full commercialization, marketing and distribution of their patented medicinal locking mechanism and bar-code matching system. Terms of the sale include a one-time payment of $7MM.
The anticipation is that the perpetual license agreement will be signed within 30 days. This is pending the results of a due diligence study by the intended buyer. The estimated dividend amount payable to each shareholder of one common stock is $0.01.
Medisafe 1 Technologies Corp. (MFTH), closed Tuesday’s trading session at $0.0062, up 55.00%, on 57,547,542 volume with 507 trades. The average volume for the last 60 days is 8,155,398 and the stock's 52-week low/high is $0.001/$0.039.
Hubei Minkang Pharmaceutical Ltd. (HBMK)
FeedBlitz reported earlier on Hubei Minkang Pharmaceutical Ltd. (HBMK), and today we are reporting on the Company, here at the QualityStocks Daily Newsletter.
Founded in 1950, Hubei Minkang Pharmaceutical Ltd. (Hubei Minkang), by way of their subsidiary Hubei Minkang Pharmaceutical Co., Ltd. (Hubei Minkang PRC), produces and markets traditional Chinese medicines. Hubei Minkang PRC is a modern pharmaceutical company that produces and markets these medicines as well as some chemical pharmaceuticals in China. Hubei Minkang is based in Yichang, Hubei, China. The Company’s shares trade on the OTCQB.
Additionally, Hubei Minkang PRC markets their products to the U.S., Japan, Canada, Singapore, Malaysia, Thailand and Hong Kong among other nations. Their products include pills, capsules, granules, oral solutions, tablets, syrups, mixtures, and injections. Hubei Minkang PRC has three Good Manufacturing Practice (GMP) certifications, with seven production lines capable of producing 10 different product types in over 400 formulations and dosages.
Earlier this year, Hubei Minkang Pharmaceutical announced that their Chinese subsidiary, Hubei Minkang Pharmaceutical Co., Ltd. (Hubei Minkang PRC) signed a Memorandum of Understanding (MOU) with Henan Wanlong Pharmaceutical Co., Ltd. (Henan Wanlong) of Zhengzhou, Henan, China with respect to a proposal for Hubei Minkang PRC to acquire 51 percent of Henan Wanlong to expand distribution and increase sales growth.
Henan Wanlong is a sales distribution company focusing on supplying injection drugs to hospitals throughout China. According to Hubei Minkang's President, CEO and Director, Lee Tong Tai, the MOU with Henan Wanlong is another key step in Hubei Minkang's ongoing strategic plan to expand their distribution network throughout China.
Hubei Minkang management anticipates proceeding with expansion plans to acquire at least a 51 percent interest of the aforementioned sales distribution company for approximately $1.5 million and to increase commercialization of Hubei Minkang PRC's products. This includes the marketing distribution of existing and potential future products, which is anticipated to cost approximately $700,000.
The Company’s strategy for producing high quality TCM products in an environmentally friendly manner using advanced technology and techniques, and distributing the products throughout China and the world is to focus production on their highest margin products; continuously improve production facilities and processes; lower production costs while maintaining product quality; and increasing direct sales while reducing distribution costs. Their strategy also includes acquiring control of raw material supply; developing and acquiring new products for manufacture; and expanding distribution throughout China and internationally.
Hubei Minkang Pharmaceutical Ltd. (HBMK), closed Tuesday’s session at $1.79, up 19.33%, on 4,350 volume with 6 trades. The average volume for the last 60 days is 1,131 and the stock's 52-week low/high is $0.15/$2.00.
Pazoo, Inc. (PZOO)
PennyStockRewards.co, Your Stock Alert, The Stock Brainiac, and SmallCapVoice reported this month on Pazoo, Inc.(PZOO), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.
Pazoo, Inc. operates as an online retailer and distributer of health and wellness products and services. Through their website, pazoo.com, the Company offers a selection of nutritional foods/supplements, drinks, wellness goods, fitness apparel, and health improvement advice. Pazoo formerly went by the name IUCSS, Inc. They changed their name to Pazoo, Inc. in May of 2011. Pazoo has their corporate headquarters in Cedar Knolls, New Jersey.
The Company's website provides a warehouse of competitively priced products and a variety of experts delivering vital information. Their site features industry experts from the health and wellness industry and the pet industry. Pazoo.com offers a unique, multi-dimensional interactive website. On the Company’s site, consumers can gain insights into health and wellness for themselves and their pets from leading industry experts. Mr. David M. Cunic, a successful physical therapist and personal trainer, founded Pazoo in 2010.
Last week, Pazoo announced that the health and wellness social community and expert section on www.pazoo.com is now active. A number of the experts on the site have started blogging and providing valuable information for participants to help improve the everyday health and wellbeing for people and their pets. The Company’s health and wellness social community will consist of blogs by their experts; in the near future it will include an interactive section where participants may ask questions and comment on their experts’ blogs. Shortly thereafter, www.pazoo.com will contain an active live chat room for the public to interact with one another to share ideas and experiences.
Today, Pazoo presented for distribution the MAX Line of Health, Wellness and Nutri-Ceutical Products. The first product releases will be the MAXPLUS Multivitamin Powered by CELLMAX and CELLMAX Stem cell nutrition concentrate. To follow in the fourth quarter of this year will be a water oxygenator for people as well as one for pets. By the end of 2012, or early in the first quarter of 2013, an anti-aging product will be added to the MAX Line and a MAX line product for aches and pains. Trademark applications have undergone filing to protect the branding of this new line allowing the Company to bring these products to market.
Pazoo, Inc. (PZOO), closed Tuesday’s trading session at $0.35, up 1.45%, on 398,054 volume with 107 trades. The average volume for the last 60 days is 95,542 and the stock's 52-week low/high is $0.09/$0.41.
Golden Queen Mining Co. Ltd. (GQMNF)
Today we are reporting on Golden Queen Mining Co. Ltd.(GQMNF), here at the QualityStocks Daily Newsletter.
Founded in 1985, Golden Queen Mining Co. Ltd. is an exploration stage company. The Company engages in acquiring and maintaining gold and silver mining properties for exploration, future development, and production. Golden Queen has interests in the Soledad Mountain project in the south of Mojave in Kern County in southern California. The Company has their headquarters in West Vancouver, British Columbia. Today, the OTC Markets Group, Inc. (OTCM), announced that Golden Queen Mining (OTCQX: GQMNF; TSX: GQM), is now trading on the highest OTC marketplace, OTCQX®. Golden Queen began trading today on the OTC market's prestigious tier, OTCQX International.
Golden Queen Mining plans to develop a gold-silver, open pit, heap leach operation on their Soledad Mountain property. The Project will use conventional open pit mining methods and the cyanide heap leach and Merrill-Crowe processes to recover gold and silver from crushed, agglomerated ore. The planned, average ore and waste mining rates are 4.71 million tons and 7.03 million tons annually, with a stripping ratio of 1.49:1 for a combined mining rate of ore and waste of 11.74 million tons annually. The permitted combined ore and waste mining rate is 14 million tons annually.
The projection for Gold and Silver production is calculated to average approximately 75,000oz and 860,000oz respectively annually. However, the expectation is that this will fluctuate substantially from year to year depending upon the ore head grades. Gold and silver production is projected to be 1,047,625 oz of gold and 11,699,000 oz of silver over a period of 15 years.
Golden Queen Mining announced that they started an infill drill program in a news release on October 21, 2010. The drill program began in April of 2011; it completed in early May of 2011. An independent consulting engineering firm based in Sparks, Nevada integrated the results from the infill drill program with a lower cutoff grade. The basis of the cutoff grade to date had been upon gold and silver prices, operating cost estimates, and gold and silver recoveries from the late 1990’s.
The consulting engineers completed a detailed analysis of the geological model and the block model. The past mineral resource and mineral reserve estimates for the Project are undergoing updating. They will be released once available, in accordance with the provisions of Canadian National Instrument 43-101 (NI 43-101). The expectation is that the work will be completed in the third quarter of this calendar year.
Golden Queen Mining Co. Ltd. (GQMNF), closed Tuesday’s trading session at $2.46, down 3.53%, on 46,002 volume with 82 trades. The average volume for the last 60 days is 57,992 and the stock's 52-week low/high is $1.76/$4.01.
Penson Worldwide, Inc. (PNSN)
OTCPicks reported yesterday on Penson Worldwide, Inc. (PNSN), SmarTrend Newsletters, StreetInsider, Millenium-Traders, Bull in Advantage did earlier, and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.
Founded in 1995, Penson Worldwide, Inc. is a provider of clearing and clearing related operational and technology services. The Company provides these services principally through their operating subsidiaries Nexa Technologies, Inc., Penson Financial Services Canada, Inc., and other companies, and their investment in Apex Clearing Holdings LLC. Penson Worldwide serves online, direct access, and institutional and traditional retail brokers. The Company also serves banks and financial technology firms. Penson Worldwide is headquartered in Dallas, Texas. The Company’s shares trade on the NASDAQ Global Select market.
Their Nexa Technologies subsidiary provides powerful trading platforms, connectivity, and market data. They provide these to over 100 retail and professional brokerage firms and banks throughout North America, Europe, and Asia. Nexa Technologies was founded in 1999 in Irvine, California. They quickly launched the first retail multi-lingual trading application in 2000. Subsequently, in 2001, Nexa entered into a strategic and financial partnership with Penson Worldwide.
Nexa Technologies’ emphasis is on operations. Their focus is on enhancing clients’ business models and creating custom solutions with products designed to increase clients’ market presence. This subsidiary’s software uses a common architecture so that all management activities are easily integrated and centralized, regardless of which product is being utilized. Nexa has successfully serviced many active brokerage operations and high-volume hedge funds.
The Company’s Penson Financial Services Canada, Inc. is a leading independent clearing firm in Canada. Penson Worldwide’s facilities in Canada, the United States, the United Kingdom, and Australia play an important role in trade execution, clearing, and custody across worldwide markets. Penson Financial Services Canada is a technology focused securities services outsourcing provider. They offer customized solutions to financial institutions globally. They offer a complete range of services including custody, trade settlement, clearing and income processing. Their specialization and focus is strictly on providing outsourced services to financial firms.
Penson Worldwide’s Apex Clearing is an independent, privately held clearing services firm in the United States. Apex provides ongoing, sustained support of their customers’ clearing needs. They have a sophisticated technology platform and their focus is a disciplined approach to risk.
Penson Worldwide, Inc. (PNSN), closed Tuesday’s trading session at $0.0752, up 4.16%, on 241,861 volume with 87 trades. The average volume for the last 60 days is 299,535 and the stock's 52-week low/high is $0.0512/$2.21.
Cellceutix Corp. (CTIX)
AllPennyStocks and FeedBlitz reported earlier on Cellceutix Corp. (CTIX), and today we choose to highlight the Company, here at the QualityStocks Daily Newsletter.
Listed on the OTCQB, Cellceutix Corp. is an emerging bio-pharmaceutical company with corporate headquarters in Beverly, Massachusetts. The Company focuses on the development of their pipeline of compounds targeting areas of unmet medical need. Their flagship compound is the anti-cancer drug Kevetrin™. This compound reactivates p53, the “Guardian Angel of the Human Genome.”
Kevetrin™ has demonstrated the ability, in pre-clinical studies, to regulate the p53 pathway and attack cancers which have proven resistant to today's cancer therapies (drug-resistant cancers). In addition, the Company owns the rights to seven other drug compounds. These include Prurisol, which is in development for psoriasis, and KM-391 for the treatment of the core symptoms of autism.
Concerning Prurisol ™ (KM-133), Cellceutix has been advised by the U.S. Food and Drug Administration (FDA), that a 505(b)(2) application would be an acceptable approach for Prurisol™. A section 505(b)(2) designation allows the Company to forgo early-stage trials and advance Prurisol™ into Phase 2\3 trials, later-stage clinical trials.
Cellceutix’ third most advanced compound in development is KM-391. It has already received a significant amount of media attention as it is one of the few drugs that is targeting the core issues of autism rather than merely treating the symptoms. The Company states that early pre-clinical research is proving extremely promising.
Last week, Cellceutix announced that they concluded negotiations and selected Dr. Reddy's Laboratories Ltd., a New York Stock Exchange-listed company traded under the symbol "RDY," for the manufacturing of Prurisol™, Cellceutix’ new drug candidate.
Yesterday, Cellceutix announced that the Company is in discussions with a major university in Europe desiring to conduct clinical trials on Kevetrin™. The University, ranked in the top ten of universities in Europe by review firm 4 International Colleges & Universities, wishes to test Kevetrin™ as a combination therapy for leukemia with drugs proprietary to one of the world's largest pharmaceutical companies. Pursuant to a confidentiality agreement, Cellceutix cannot identify the University or the pharmaceutical company at the present time.
Cellceutix Corp. (CTIX), closed Tuesday’s trading at $0.75, up 4.17%, on 2,442,740 volume with 522 trades. The average volume for the last 60 days is 107,532 and the stock's 52-week low/high is $0.30/$0.77.
Legend Oil and Gas, Ltd. (LOGL)
SmarTrend Newsletters reported recently on Legend Oil and Gas, Ltd. (LOGL), and today we choose to report on the Company, here at the QualityStocks Daily Newsletter.
Listed on the OTCQB, Legend Oil and Gas, Ltd. is a managed risk, oil and gas exploration/exploitation, development, and production company. They have activities presently focusing on leases in Canada, south-eastern Kansas and northern North Dakota. Legend is pursuing "Blue Sky" assets with significant exploration and development potential. The Company is based in Seattle, Washington.
Legend Oil and Gas' core asset is in Alberta, Canada. The Company also has leaseholds in Piqua, Kansas and the prolific Bakken Formation in North Dakota. The Canadian assets acquired by Legend Oil and Gas, administered within their wholly owned subsidiary Legend Energy Canada Ltd., contain oil and gas properties currently producing almost 300 BOE/d. The properties contain a mix of 37 percent oil and natural gas liquid production, and 63 percent gas production. The bulk of the properties are located in Alberta. However, almost 41 percent of the total sales are taken from the Province of British Columbia, located directly west of Alberta.
Legend Oil and Gas acquired the Piqua Kansas project effective October 29, 2010. A detailed review of the property yielded a 46 well count for producers, six shut in wells, 13 injection wells, two water source wells, and one water disposal location. These have all been catalogued with the Kansas Corporations Commission and are now the official well count for Legend's interests at Piqua.
Legend Energy Canada entered into a two well drilling commitment with a third party to drill two deep test wells on their Virginia Hills and Swan Hills properties in west central Alberta. The Company is also continuing to pursue a drilling program on their Swan Hills area Slave Point formation horizontal project.
Last week, Legend Oil and Gas announced that they completed Phase 1 of their multi-well drilling program at their Piqua Property in south-eastern Kansas. Marshall Diamond-Goldberg, President of Legend Oil and Gas stated, "Results from the first four wells are very encouraging as all encountered thicker than anticipated oil-saturated Squirrel sand at the expected depths. We will likely test the upper Squirrel independently to determine its productivity capacity. The upper Squirrel is productive elsewhere, but has not yet been produced in the Piqua area, and we believe this presents a potential production opportunity for the Company."
Legend Oil and Gas, Ltd. (LOGL), closed Tuesday’s trading session at $0.103, even for the day, on 122,475 volume with 27 trades. The average volume for the last 60 days is 49,109 and the stock's 52-week low/high is $0.105/$2.45.
Questerre Energy Corp. (QEC.TO)
Stockhouse and Super Stock Picker reported earlier on Questerre Energy Corp. (QEC.TO), and we are reporting on the Company, here at the QualityStocks Daily Newsletter.
Questerre Energy Corp. is an independent energy company with corporate headquarters in Calgary, Alberta. They focus on unconventional oil and gas projects. The Company is developing oil shale to create shareholder value and developing conventional production to create reserve of capital. Questerre has three existing projects with the objective of adding net recoverable resources in excess of several hundred million barrels. Questerre Energy’s shares trade on the Toronto Stock Exchange,.
Questerre is developing a portfolio of light oil assets primarily in Saskatchewan, Canada. They are drilling for Bakken/Torquay light oil pool in Saskatchewan. Recent drilling success for liquid-rich Montney (Conventional Oil) in the Province of Alberta creates a new core area. Furthermore, the Company’s Nonconventional Oil in Eastern Saskatchewan is 100,000 net acres overlying an established deposit. The 2012 winter work program completed with 10 core holes to assess potential.
Questerre Energy is also taking advantage of their expertise to commercialize their Utica shale gas discovery in the St. Lawrence Lowlands, Quebec (Nonconventional Gas/Shale Gas). They are securing a social license to operate for a major gas resource discovery. There is an 18 Tcf (3 billion boe) prospective recoverable resource in the Utica shale on Questerre’s acreage in Quebec with 4.4 Tcf net to Questerre Energy. The core land position was acquired and the tenure was recently extended to 2021. A comprehensive strategic environmental assessment (SEA) is underway.
Their other Nonconventional Oil assets are in Utah and Wyoming. The Company has a commercialization project in Utah and an early stage project in Wyoming. In Wyoming, Questerre Energy is to earn 20 percent on a 5,120 acre farm-in on private lands with Red Leaf holding an 80 percent interest. Red Leaf estimates 800 million barrels of oil in place. Questerre Energy is developing a work program for 2012‐2013 to assess oil shale. Questerre has a non-exclusive option to license the Red Leaf process and technology but it is exclusive for any Questerre initiated projects.
In August, Questerre Energy reported that drilling operations have started on their second well targeting the liquids-rich window of the Montney shale in the Resthaven area of west central Alberta. This follows the discovery well that tested at gross rates of more than 2,500 boe/d. The Company also updated the status of the first well. The construction of the main pipeline to a third party processing plant is underway and is scheduled for completion by the end of the third quarter.
Questerre Energy Corp. (QEC.TO), closed Tuesday at $0.77, up 14.93% , on 931,067 volume. The stock's 52-week low/high is $0.59/$1.07.
Duma Energy Corp. (DUMA)
The QualityStocks Daily Newsletter would like to spotlight Duma Energy Corp. (DUMA). Today, Duma Energy Corp. closed trading at $1.90, up 8.57%, on 12,266 volume with 21 trades. The stock’s average daily volume over the past 60 days is 7,571, and its 52-week low/high is $1.50/$4.00.
Duma Energy Corp. and Hydrocarb Energy Corp. reported the completion of a farm-out agreement today, with Duma gaining a 39% working interest in the 5M-acre Owambo concession in northern Namibia, a vast, underexplored site with a potential billion barrels of un-risked resource potential from a single identified structure according to a recent third party report.
Duma Energy Corp. (DUMA) is an aggressive growth company actively producing oil and gas in the domestic United States, both on and offshore. Leveraging its technical expertise, promising portfolio, and strong financial condition, the company plans to utilize domestic revenues and cash flow to fund its rapid growth through acquisition, while participating in transformational projects with the potential of providing exponential returns for shareholders.
The company's primary goal for fiscal year 2012 and beyond is to drive earnings growth. The company also aims to pursue listing on major exchange(s) to provide better visibility and liquidity to shareholders and financial partners. Already producing and generating revenue from oil and gas in Texas, Illinois, and Louisiana, Duma projects domestic production to exceed 1,000 barrels of oil equivalent per day (boepd) by the end of 2012; with 2,500 boepd projected by the end of 2013.
Duma was founded in 2005 and began trading on the OTCBB in 2009 via registration. In 2006, the company began producing from its first properties in Texas and soon after added production in Louisiana. In 2009, its new CEO Jeremy G. Driver came on board. Within one year, Mr. Driver had identified and negotiated an acquisition that would fundamentally reshape the company. This acquisition was made possible by the large direct cash investment by Mr. Driver and his family, as well as other investors.
The company uses only industry standard and time-tested technologies, and avoids unproven "resource plays" and other opportunities that are heavily dependent upon high commodity prices. Not bound by any geographical location or operational strategy, Duma's management team is focused on developing its existing portfolio while pursuing additional opportunities that provide rapid growth, leveraging growing revenue, cash flow, and reserves to accelerate its growth strategy. Disclaimer
Duma Energy Corp. Company Blog
Duma Energy Corp. News:
Duma Energy Corp. Partners with Hydrocarb to Explore for World Class Reserves in Africa Oil Concession
Duma Energy Receives Approval From Government of Namibia for Exploration License Issued for 5.3 Million-Acre Concession
Duma Energy Acquires Interest in 5.3 Million-Acre African Concession
TNI BioTech, Inc. (TNIB)
The QualityStocks Daily Newsletter would like to spotlight TNI BioTech, Inc. (TNIB). Today, TNI BioTech, Inc. closed trading at $0.99, off by 4.81%, on 26,190 volume with 23 trades. The stock’s average daily volume over the past 60 days is 10,023, and its 52-week low/high is $0.85/$10.01.
TNI BioTech, Inc. reported signing a Memorandum of Agreement today with MOV-FAS S.A. to open a 20k square meter pharmaceutical plant in Managua economic free zone, Nicaragua. The GMP-compliant facility is slated to be complete by late October this year and will be used for manufacturing some 1.4B capsules of Low-Dose Naltrexone under the trade name of IRT-103 per year that is destined for the large African market, as well as nearby export markets.
TNI BioTech, Inc. (TNIB) is focused on utilizing patented immunotherapy to activate and mobilize the body's immune system to combat fatal diseases. The company's products and technologies improve the treatment and diagnosis of cancer, infections such as HIV/AIDS, and autoimmune diseases. Future initiatives include treatment for multiple sclerosis, herpes viral infections, and other conditions that result in altered-immune response.
The company's product portfolio currently includes IRT-101, an active immunotherapy that works by activating a patient's immune system against infectious diseases and tumor cells; IRT-102, an adaptive immunotherapy that works by isolating and enriching a patient's own immune cells; and IRT-103, an active immunotherapy that works by activating a patient's immune system against HIV/AIDS and tumor cells.
Leveraging the advantages of today's cutting-edge treatment options, the company aims to meet the growing demand for quality healthcare with safer, more effective radiation therapy; new-targeted drug therapies; and minimally invasive surgical alternatives around the world. TNI BioTech most recently signed a letter of intent to open clinics in Africa that will provide advanced treatment for cancer, HIV/AIDS, and autoimmune diseases.
The company plans to continue clinical trials in China during 2012 and 2013, and anticipates starting trials in the United States by early 2013.The company is also in negotiations to acquire a number of other immunotherapy products, patents, and therapies. Led by a management team with decades of experience and solid business plan, TNI BioTech is poised to improve healthcare with active and adaptive forms of improved immunotherapies. Disclaimer
TNI BioTech, Inc. Company Blog
TNI BioTech, Inc. News:
TNI BioTech, Inc. Signs Memorandum of Agreement to Open Pharmaceutical Plant for the Production of IRT-103 (LDN)
Dr. Ronald Herberman Joins TNI BioTech Inc. as Senior Vice President of Research and Development and Chief Medical Officer
TNI BioTech, Inc. Acquires Portfolio of Exclusive Licenses to the Portfolio of Patents of Dr. Bernard Bihari
Loans4Less.com, Inc. (LFLS)
The QualityStocks Daily Newsletter would like to spotlight Loans4Less.com, Inc. (LFLS). Today, Loans4Less.com, Inc. closed trading at $0.07, up 76.19%, on 10,000 volume with 1 trades. The stock’s average daily volume over the past 60 days is 24,140, and its 52-week low/high is $0.001/$0.51. .
Loans4Less.com, Inc. (LFLS) is an online mortgage broker which matches qualified individuals seeking mortgage loans with suitable lenders who offer the company a competitive wholesale lending program. Maintaining an A+ TrustLink rating with the Better Business Bureau, the company provides competitive rates, terms, costs, daily updates, extensive market information, and trusted first-class service to the public.
Leveraging its portfolio of 62 different web domains, Loans4Less.com is focused on developing a national consumer platform for conforming residential mortgage programs and implementation of other consumer loan programs via operating providers. The company's expansion strategy includes rapidly growing revenues through strategic and cost-effective advertising, licensing, and/or third party agreements that build national recognition of the Loans4Less® brand.
The management team has accumulated many years of experience in the real estate and financial services sectors. This combination of expertise provides the knowledge and foresight necessary to get the best results for the company and their thousands of loyal clients. The team skillfully navigated through the credit crisis that destroyed much of their competition, putting the company in a stronger position to increase market share.
Loans4Less.com is not exposed to the risks and/or problems that are associated with sub-prime lending. Having never defaulting on an obligation or been involved in any litigation, the company is poised for rapid growth in today's low interest rate environment with its industry leading reputation and well established relationships with respected lenders. Disclaimer
Loans4Less.com, Inc. Company Blog
Loans4Less.com, Inc. News:
Loans4Less.com, Inc. Announces Engagement of QualityStocks Investor Relations Services.
GlobalWise Investments, Inc. (GWIV)
The QualityStocks Daily Newsletter would like to spotlight GlobalWise Investments, Inc. (GWIV). Today, GlobalWise Investments, Inc. closed trading at $0.80, up 14.29%, on 10,500 volume with 6 trade. The stock’s average daily volume over the past 60 days is 5,348, and its 52-week low/high is $0.61/$1.87.
GlobalWise Investments, Inc. (GWIV), via wholly-owned subsidiary Intellinetics, Inc., is a leading-edge technology company focused on Enterprise Content Management (ECM) solutions for the digital age. The ECM industry continues to grow rapidly as a result of unrestricted proliferation of digital content within today's business environment. Leveraging its proprietary cloud-based computing software, GlobalWise is poised to capture a significant market share of this burgeoning industry.
GlobalWise's ECM service is delivered to customers via five unique delivery models which cover the spectrum of business needs: Cloud/Saas (Software as a Service), Hardware Vendor Integrated Service, Software Vendor Integrated Service, Premise (Client-Server), Hybrid (Premise & Cloud/Saas).This diversity gives advanced security & privacy features with an on-demand structure needed for large Tier 3 and Tier 4 businesses that are currently underserved by the market.
The Intellinetics platform defines a new industry benchmark and game-changing approach by combining advanced virtualization & automated content management with an open and service-oriented architecture using web services. The company provides strategies, tactics, and technologies used to manage paper and digital assets from capture to long-term archive, without the need for manual processes conducted by a full time employee.
GlobalWise's management boasts a combined total of over 60 years in ECM leadership and industry experience. The ECM industry is expected to exceed $5.1 billion by 2013 with Gartner predicting a compound annual growth rate of 9.5%. IBM Market Insights predicts adoption of cloud computing to grow by 26% CAGR between 2010 through 2013. Leveraging management and key department heads, Intellinetics has a strong foundation from which to capture significant market share within the lucrative $149 billion Business Software & Services industry. Disclaimer
GlobalWise Investments Company Blog
GlobalWise Investments News:
GlobalWise Channel Partner Training Programs Provide Growth Accelerator
GlobalWise Announces New Channel Sales Partnership With RJ Young
GlobalWise Accepted as Member of Prestigious Organization Technology United
Hydrocarb Energy just announced the completion of a farm-out agreement to Duma Energy Corporation. Houston-based Duma, with current production in the Gulf Coast, indirectly owns a 39% working interest in Owambo blocks 1714A, 1715, 1814A, and 1815A in northern Namibia.
“Our vast and underexplored concession shows tremendous potential based on the data available to date,” stated Kent Watts, Hydrocarb’s Chief Executive. “We have reviewed a third party report already estimating over a billion barrels of un-risked resource potential out of a single identified structure. The Duma partnership allows us to move aggressively towards our ultimate goal, to make a major discovery in Namibia. We anticipate building on new technical findings as the exploration process unfolds.”
Encompassing over 5 million acres, the concession is about the size of Massachusetts. Northern Namibia has all of the key elements needed to become a major oil province, including good reservoir and source rocks. Hydrocarb, as 51% owner, retains its role as operator on all blocks. The new partnership includes NAMCOR, the Namibian National Oil Company, as a 10% partner and Duma at 39%. The commercial terms for the Owambo Petroleum Contract are highly favorable with reasonable onshore operating and exploration costs. According to today’s release, Namibia is one of the most stable countries in Africa.
Even though its extensive resources are well known, Africa remains greatly under-explored. Recent discoveries of large oil and gas reserves by companies such as Kosmos and Tullow PLC suggest oil and gas production in Africa may be on the verge of dramatic growth. Major and independent players such as Chevron (NYSE: CVX) and Hyperdynamics (NYSE: HDY) retain huge acreage positions and are budgeting billions of dollars for exploration.
Duma Energy Corp.’s Chief Executive, Jeremy Driver, commented, “Our concession is in the Namibian portion of the Owambo Basin which extends into southern Angola and is one of the largest unexplored onshore basins in Africa. This partnership with Hydrocarb fits our core strategy to continuously develop profitable production domestically while also participating in high impact opportunities internationally that have world class potential.”
For additional information on Duma Energy, visit the company’s website at www.DUMA.com
Today before the opening bell, TNI BioTech, a biotech company focused on combating fatal diseases through the activation and mobilization of the body’s immune system, reported that a Memorandum of Agreement has been signed involving the company and MOV-FAS S.A. to open a pharmaceutical plant in Managua, Nicaragua.
TNIB has acquired a portfolio patents involving Low-Dose Naltrexone (LDN) for the treatment of HIV/AIDS, cancer and other diseases. This acquisition includes more than two decades of data showing Low Dose Naltraxone (LDN) as an effective immune system modulator, without significant toxic side effects or addicting properties, and can be administered by a single capsule taken daily. In anticipation of meeting existing obligations, as well as contracts under negotiation, TNI BioTech reached an agreement with MOV-FAS S.A. to finance and construct a pharmaceutical plant for the production of IRT-103.
According to today’s press release, the new plant will occupy approximately 20,000m² of area in Managua, Nicaragua; an economic free zone designed to promote industrial growth and development in the Managua area. The company secured a lease on the premises with plenty of room for future expansion. Plant construction began in September of 2012 and is being built pursuant to international pharmaceutical GMP (Good Manufacturing Practice) standards. The TNI BioTech facility is expected to be fully operational by the end of next month.
LDN is to be manufactured under the trade name of IRT-103 with the intention of selling the product in Africa and nearby export markets. The plant has the capacity to manufacture approximately One Billion Four Hundred Thousand (1,400,000,000) capsules year.
A partially owned subsidiary was formed by TNI Biotech for this joint venture. The partners in this joint venture are TNI BioTech (which owns 55%); MOV-FAS S.A., the development company (which owns 35%); Pharmaceutical Care Consultant of South Florida, d/b/a Skips Pharmacy (which owns 5%); and GB Pharma Holdings LLC, a subsidiary of GB Oncology & Imaging Group LLC (which owns 5%). TNI BioTech anticipates providing most of the technology; Pharmaceutical Care Consulting will provide quality control and management; GB Oncology & Imagining Group, LLC has provided the initial contracts for the sale of IRT-103; and MOV-FAS will provide the initial capital, the land, and building, but more importantly, local relations to handle all permitting and approval for the venture.
Frank Owens, the managing member of MOV-FAS S.A., and a successful entrepreneur with over 30 years of experience in building and operating businesses in Central and South America, stated, “We are on target to open the new pharmaceutical facility October 15, 2012. The facility will be expanded from production for One Hundred Thousand (100,000) capsules a day to Four Million (4,000,000) capsules per day as demand for the product increases. MOV FAS entered this venture because it believes the project will be a financial success, and simultaneously allow us to provide low cost effective treatments for HIV/AIDS and autoimmune diseases to millions of people in developing nations.”
Christopher Pearce, CFO of TNI BioTech, Inc., added, “TNI BioTech looks forward to working with noted, successful and innovative businessmen such as Mr. Frank Owens and Robert E. Friedrich. Their extensive experience in the field of business development and manufacturing provides the company with a partner ensuring TNIB can meet its IRT-103 delivery contracts beginning the last quarter of 2012.”
Noreen Griffin, TNI BioTech, Inc. CEO, commented, “The opening of this facility is very important for TNIB, as it is a significant step in the company’s development of its licensed, patented, low cost effective treatment for a number of autoimmune diseases and will provide revenue for the company.”
To learn more about the company and its immunotherapy technologies, visit www.tnibiotech.com
Longhai, through its Chinese operating company, produces various sizes of high quality steel wire products in two wire production plants, with a total annual capacity of approximately 1.5 million metric tons. The company’s output is sold to several distributors who in turn send it to nearby wire processing companies, with the final product being screws, nails, and wire mesh used for reinforced concrete and fencing. A recently opened second production line also produces higher quality steel wire for use in steel wire rope, welding rods, and steel belted radial tires. Longhai has also acquired land next to the two existing plants for the future addition of a third production facility.
Longhai’s production operations are located in Xingtai, Hebei province, south of Beijing, and cover roughly 200,000 square meters. Production design is geared to yield high quality, high volume, and low cost per ton. The newest facility incorporates Sixth Generation technology with air cooling that enables the production of even higher quality and more specialized steel wire. Longhai is ISO9001-2000 and GB/700-88 certified.
Longhai manufactures on demand, with sales prices set daily at the market price, though the company occasionally offers discounted wholesale prices, with sales efforts aimed at establishing long-term relationships with large volume customers. Steel billet is purchased subsequent to receipt of customer orders, helping protect the company from commodity price volatility. All distribution is within China, with 80% of it within Hebei province. Hebei is China’s biggest single steel making province, but is also a major producer of textiles, coal, iron, and chemicals.
The combination of the latest production technologies, together with an excellent distribution location and customer relationships that allow for customer prepayment, give Longhai an exceptionally solid operational foundation.
For additional information, visit the company’s website at www.LonghaiSteelInc.com
Lithium Corporation, the junior mineral development firm focused on its primary suite of three wholly-owned prospects in Nevada, each with a defined lithium/brine surface target and quantifiable lithium anomalies, was happy to report successful execution today of a key step towards listing on the Canadian National Stock Exchange (CNSX) via the filing of an application with the BC Securities Commission (BCSC).
LTUM has also filed a Preliminary Long Form Prospectus with the BCSC in support of this move, which includes a 43-101 report (James Chapman, P. Geo) on the company’s flagship Fish Lake Valley prospect that should help solidify the listing move considerably, resulting in a huge boost to the company’s overall exposure. Canadian equity markets are so bullish on commodities and mining that the move seems like a real no-brainer for LTUM, whose shareholders will benefit handsomely from the increased liquidity and equity financing options created thereby.
Fish Lake Valley has shown considerable lithium buildup in the roughly 6,400 acres of placer claims (with secondary potassium and boron), with near identical geology to Chemtall Foote’s Silver Peak operation 22 miles southeast. Evaporative brine mining is quite easy by comparison with hard rock extractions, and the surficial lithium enrichment at Fish Lake Valley looks on par with Silver Peak in all respects, even drawing comparison to the lithium-rich salars (salt flats) in Chile and elsewhere.
Given the unprecedented rise in demand for lithium in recent years because of how essential it is for the long-life batteries found in nearly every portable electronic device made today, including mobile smartphones, laptops, and tablet computers, LTUM is ingeniously positioning itself in domestic lithium production ahead of the obvious future trend. What with electric vehicles set to become increasingly predominant moving forward, we will see another mounting vector in the lithium bottom line alongside smart mobile device proliferation. As onboard power demands increase across a rapidly expanding product space, the need for lithium will go supernova and LTUM is putting shareholders in the pole position to win the domestic lithium race, even as global supplies dwindle and exporters like China talk about curbing availability.
Chapman’s analysis of Fish Lake Valley roundly confirms that the site is in better shape than back in July when the company last visited the playa and that the site should be dry enough after the fall to bring in drilling equipment, with late October or early November looking like a good start window. The 0.5 sq mile focus area for drilling shows strong lithium levels (up to 140 mg/L) with excellent boron (2500 mg/L) and potassium (7200 mg/L) concentrations and sits inside a larger 1.5 by 1 mile area exhibiting similar, if less pronounced, lithium and boron concentrations.
Turning to the company’s other key project in Nevada, the some 1,600-acre block of claims that make up the San Emidio prospect, we see LTUM having staked out yet more claims on the resource-rich playa, with ongoing efforts to amend the BLM permit for further drilling. Previous values of 23.7 mg/L, with high calcium/potassium secondary targets from early 2012′s drilling, taken in context with the brine sampling returns from last year showing 66.4 mg/L, heighten the exceptional logistics available. After all, San Emidio is just 60 miles northeast of Reno and is just 8 miles off Nevada State Highway 447; the localized support for mining operations is abundant. On-site geothermal power is available via a generation plant on the south end of the prospect as well, making the San Emidio prospect particularly self-sufficient.
The company also has the Salt Wells property, acquired via staking a 12,320-acre parcel covering Eightmile Basin up near Fallon, with returns from sediment sampling on the property showing around 750 ppm Li.
Brine lithium is a cheap and easy, environmentally-friendly target for LTUM and this move to list on the Canadian exchange should open up merger options as well in an industry that is rapidly consolidating, something which could prove quite lucrative for LTUM shareholders who stand to gain from the merger mania.
For more information on today’s announcement, or to learn more about Lithium Corp., please visit the company’s website at: www.LithiumCorporation.com
Today's Top 3
The QualityStocks Public Company Sponsor News